Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 17, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
Takeda Launches Narcolepsy Drug ORZEYFUL in Japan and China, U.S. Launch Planned
Life Sciences Times
-
October 15, 2026
Pharma
Takeda Reports Positive Phase 2/3 Results for Experimental Immunodeficiency Treatment
Life Sciences Times
-
October 14, 2026
Pharma
Calluna Pharma Completes Dosing in Phase 2 Lung Fibrosis Trial, Expects Results in Early 2027
Life Sciences Times
-
October 13, 2026
Pharma
Alkermes to Present New Narcolepsy and Sleep Disorder Treatment Data at Sleep Europe 2026
Life Sciences Times
-
October 13, 2026
Pharma
Scholar Rock Resubmits European Application for Spinal Muscular Atrophy Treatment
Life Sciences Times
-
October 8, 2026
Pharma
TEZSPIRE Meets All Primary and Key Secondary Endpoints in Phase III Eosinophilic Esophagitis Trial
Life Sciences Times
-
August 27, 2026
0
Pharma
FDA Approves ViiV Healthcare’s Tivicay PD for HIV Treatment in Newborns and Young Children
Life Sciences Times
-
August 26, 2026
0
Pharma
Alkermes’ Alixorexton Shows Positive Phase 2 Results in Narcolepsy Type 1
Life Sciences Times
-
August 25, 2026
0
Pharma
Takeda’s ORZEYFUL Approved in Japan for Narcolepsy Type 1
Life Sciences Times
-
August 24, 2026
0
Pharma
Amylyx Reports Positive Phase 3 Results for Avexitide in Post-Bariatric Hypoglycemia
Life Sciences Times
-
August 18, 2026
0
Pharma
ENHERTU Improves Progression-Free Survival in First-Line HER2-Mutant Lung Cancer Trial
Life Sciences Times
-
August 17, 2026
0
Pharma
Karyopharm Reports $33.4 Million in Q2 Revenue, Plans August Selinexor sNDA Submission
Life Sciences Times
-
August 13, 2026
0
Pharma
Cycle Pharmaceuticals Taps Forma Life Sciences for U.S. Manufacturing of CAVHANZA
Life Sciences Times
-
August 13, 2026
0
Pharma
Zipalertinib-Chemotherapy Combination Meets Primary Endpoint in Phase 3 Lung Cancer Trial
Life Sciences Times
-
August 13, 2026
0
Pharma
Sumitomo Pharma America Doses First Patient in Phase 1/2a Retinitis Pigmentosa Study
Life Sciences Times
-
August 12, 2026
0
Pharma
Enanta Pharmaceuticals Reports $19.5 Million Q3 Loss, Advances RSV and Immunology Programs
Life Sciences Times
-
August 11, 2026
0
Pharma
Bristol Myers Squibb Plans $2.3 Billion Manufacturing Campus in Houston
Life Sciences Times
-
August 10, 2026
0
1
2
3
4
...
101
Page 3 of 101
Most Read
Perceptive Discovery Expands Radiopharmaceutical Research Capabilities in Massachusetts and UK
October 16, 2026
Boston-Based Clasp Launches Healthcare Job Marketplace Offering Student Loan Repayment Benefits
October 16, 2026
Ironwood Pharmaceuticals Names Tammi Gaskins CEO as Tom McCourt Announces Retirement
October 16, 2026
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
October 16, 2026